Monoclonal antibodies to equine CD23 identify the low-affinity receptor for IgE on subpopulations of IgM + and IgG1 + B-cells in horses

Veterinary Immunology and Immunopathology

Volumn 146, Issue 2, 2012, Pages 125-134

  Wagner, Bettina ^a   Hillegas, Julia M ^a   Babasyan, Susanna ^a  

^a Cornell University ^*  (United States)

Author keywords

Boost of antibody responses; IL 4 fusion protein; Low affinity IgE receptor; Monoclonal antibodies

Indexed keywords

CD23 ANTIGEN; HYBRID PROTEIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; INTERLEUKIN 4; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; HORSE; IMMUNE RESPONSE; LYMPHOCYTE SUBPOPULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RECEPTOR AFFINITY;

ANIMALS; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; BLOTTING, WESTERN; CLONING, MOLECULAR; FLOW CYTOMETRY; HORSES; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEUKOCYTES, MONONUCLEAR; RECEPTORS, IGE; RECOMBINANT FUSION PROTEINS;

EQUIDAE; MAMMALIA;

EID: 84859517235     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2012.02.007     Document Type: Article

References (49)

1. Acharya M., Borland G., Edkins A.L., Matheson J., Ozanne B.W., Cushley W. CD23/Fce{open}RII: molecular multi-tasking. Clin. Exp. Immunol. 2010, 162:12-23.
2. Armitage R.J., Goff L.K., Beverley P.C. Expression and functional role of CD23 on T-cells. Eur. J. Immunol. 1989, 19:31-35.
3. Bansal A., Roberts T., Hay E.M., Kay R., Pumphrey R.S., Wilson P.B. Soluble CD23 levels are elevated in the serum of patients with primary Sjogren's syndrome and systemic lupus erythematosus. Clin. Exp. Immunol. 1992, 89:452-455.
4. Bansal A.S., MacGregor A.J., Pumphrey R.S., Silman A.J., Ollier W.E., Wilson P.B. Increased levels of sCD23 in rheumathoid arthritis are related to disease status. Clin. Exp. Rheumatol. 1994, 12:281-285.
5. Barbis D.P., Bainbrigde D., Crump A.L., Zhang C.H., Antczak D.F. Variation in expression of MHC class II antigens on horse lymphocytes determined by MHC haplotype. Vet. Immunol. Immunopathol. 1994, 42:103-114.
6. Byrd J.C., Kipps T.J., Flinn I.W., Castro J., Lin T.S., Wierda W., Heerema N., Woodworth J., Hughes S., Tangri S., Harris S., Wynne D., Molina A., Leigh B., O'Brien S. Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia. Blood 2010, 111:1594-1602.
7. Dowdall S.M., Matthews J.B., Mair T., Murphy D., Love S., Proudman C.J. Antigen-specific IgG(T) responses in natural and experimental cyathostominae infection in horses. Vet. Parasitol. 2002, 106:225-242.
8. Ewart M.A., Ozanne B.W., Cushley W. The CD23a and CD23b proximal promoters display different sensitivities to exogenous stimuli in B lymphocytes. Genes Immun. 2002, 3:158-164.
9. Fourcade C., Arock M., Ktorza S., Ouaaz F., Merle-Béral H., Mentz F., Kilchherr E., Debré P., Mossalayi M.D. Expression of CD23 by human bone stromal marrow cells. Eur. Cytokine Netw. 1992, 3:539-543.
10. Goehring L.S., Wagner B., Bigbie R., Hussey S.B., Rao S., Morley P.S., Lunn D.P. Control of EHV-1 viremia and nasal shedding by commercial vaccines. Vaccine 2010, 28:5203-5211.
11. Goodman L.B., Wagner B., Flaminio M.J., Sussman K.H., Metzger S.M., Holland R., Osterrieder N. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1). Vaccine 2006, 24:3636-3645.
12. Gould H.J., Sutton B.J. IgE in allergy and asthma today. Nat. Rev. Immunol. 2008, 8:205-217.
13. Grangette C., Gruart V., Ouaissi M.A., Rizvi F., Delespesse G., Capron A., Capron M. IgE receptor on human eosinophils (Fce{open}RII). Comparison with B cell CD23 and association with an adhesion molecule. J. Immunol. 1989, 143:3580-3588.
14. + spleen or bone marrow cells. J. Immunol. 2000, 164:3990-3995.
15. Hallek M., Pflug N. Chronic lymphocytic leukemia. Ann. Oncol. 2010, 21:vii154-vii164.
16. Hibbert R.G., Teriete G., Grundy G.J., Beavil R.L., Reljic R., Holers V.M., Hannan J.P., Sutton B.J., Gould H.J., McDonnell J.M. The structure of human CD23 and its interaction with IgE and CD21. J. Exp. Med. 2005, 202:751-760.
17. Huissoon A.P., Emery P., Bacon P.A., Gordon J., Salmon M. Increased expression of CD23 in rheumatoid synovitis. Scand. J. Rheumatol. 2000, 29:154-159.
18. Jackson K.A., Stott J.L., Horohov D.W., Watson J.L. IL-4 induced CD23 (FcepsilonRII) up-regulation in equine peripheral blood mononuclear cells and pulmonary alveolar macrophages. Vet. Immunol. Immunopathol. 2004, 101:243-250.
19. Joseph M., Capron A., Ameisen J.C., Capron M., Vorng H., Pancre V., Kusnierz J.P., Auriault C. The receptor for IgE on blood platelets. Eur. J. Immunol. 1986, 16:306-312.
20. Kabithe E., Hillegas J., Stokol T., Moore J., Wagner B. Monoclonal antibodies to equine CD14. Vet. Immunol. Immunopathol. 2010, 138:149-153.
21. Lemieux G.A., Blumenkron F., Yeung N., Zhou P., Williams J., Grammer A.C., Petrovich R., Lipsky P.E., Moss M.L., Werb Z. The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10. J. Biol. Chem. 2007, 282:14836-14844.
22. Lopez A.M., Hines M.T., Palmer G.H., Knowles D.P., Alperin D.C., Hines S.A. Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi. Vaccine 2003, 21:3815-3825.
23. Lunn D.P., Holmes M.A., Antczak D.F., Agerwal N., Baker J., Bendali-Ahcene S., Blanchard-Channell M., Byrne K.M., Cannizzo K., Davis W., Hamilton M.J., Hannant D., Kondo T., Kydd J.H., Monier M.C., Moore P.F., O'Neil T., Schram B.R., Sheoran A., Stott J.L., Sugiura T., Vagnoni K.E. Report of the second equine leukocyte antigen workshop, Squaw valley, California, July 1995. Vet. Immunol. Immunopathol. 1998, 62:101-143.
24. Massa M., Pignatti P., Oliveri M., De Amici M., De Benedetti F., Martini A. Serum soluble CD23 levels and CD23 expression on peripheral blood mononuclear cells in juvenile chronic arthritis. Clin. Exp. Rheumatol. 1998, 16:611-616.
25. McCloskey N., Hunt J., Beavil R.L., Jutton M.R., Grundy G.J., Girardi E., Fabiane S.M., Fear D.J., Conrad D.H., Sutton B.J., Gould H.J. Soluble CD23 monomers inhibit and oligomers stimulate IgE synthesis in human B-cells. J. Biol. Chem. 2007, 282:24083-24091.
26. Mealey R.H., Ueti M.W., Kappmeyer L.S., Wagner B., Knowles D.P. Protective effects of passively transferred merozoite-specific antibodies against Theileria equi in horses with severe combined immunodeficiency. Clin. Vaccine Immunol. 2012, 19:100-104.
27. Melewicz F.M., Plummer J.M., Spiegelberg H.L. Comparison of the Fc receptors for IgE on human lymphocytes and monocytes. J. Immunol. 1982, 129:563-569.
28. Mérant C., Bonnefont C., Desbos A., Greenland T., Cadoré J.L., Monier J.C. Cross-species reactivity of seven monoclonal antibodies with equine lymphocytes by flow cytometry. Vet. Res. 2003, 34:791-801.
29. Montagnac G., Molla-Herman A., Bouchet J., Yu L.C., Conrad D.H., Perdue M.H., Benmerah A. Intracellular trafficking of CD23: differential regulation in humans and mice by both extracellular and intracellular exons. J. Immunol. 2005, 174:5562-5572.
30. Nelson K.M., Schram B.R., McGregor M.W., Sheoran A.S., Olsen C.W., Lunn D.P. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination. Vaccine 1998, 16:1306-1313.
31. Paul W.E. Interleukin 4/B cell stimulatory factor 1: one lymphokine, many functions. FASEB J. 1987, 1:456-461.
32. Platzer B., Ruiter F., van der Mee J., Fiebiger E. Soluble IgE receptors - elements of the IgE network. Immunol. Lett. 2011, 141:36-44.
33. Poole J.A., Meng J., Reff M., Spellman M.C., Rosenwasser L.J. Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects. J. Allergy Clin. Immunol. 2005, 116:780-788.
34. Ribbens C., Bonnet V., Kaiser M.J., Andre B., Kaye O., Franchimont N., de Groote D., Beguin Y., Malaise M.G. Increased synovial fluid levels of soluble CD23 are associated with and erosive status in rheumatoid arthritis (RA). Clin. Exp. Immunol. 2000, 120:194-199.
35. Rosenwasser L.J., Meng J. Anti-CD23. Clin. Rev. Allergy Immunol. 2005, 29:61-72.
36. Schultz O., Laing P., Sewell H.F., Shakib F. Der p1, a major allergen of house dust mite, proteolytically cleaves the low-affinity receptor for human IgE (CD23). Eur. J. Immunol. 1995, 25:3191-3194.
37. Sheoran A.S., Timoney J.F., Holmes M.A., Karzenski S.S., Crisman M.V. Immunoglobulin isotypes in sera and nasal mucosal secretions and their neonatal transfer and distribution in horses. Am. J. Vet. Res. 2000, 61:1099-1105.
38. Siebenkotten G., Esser C., Wabl M., Radbruch A. The murine IgG1/IgE class switch program. Eur. J. Immunol. 1992, 22:1827-1834.
39. Wagner B., Radbruch A., Rohwer J., Leibold W. Monoclonal anti-equine IgE antibodies with specificity for different epitopes on the immunoglobulin heavy chain of native IgE. Vet. Immunol. Immunopathol. 2003, 92:45-60.
40. Wagner B., Robeson J., McCracken M., Wattrang E., Antczak D.F. Horse cytokine/IgG1 fusion proteins - mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines. Vet. Immunol. Immunopathol. 2005, 105:1-14.
41. Wagner B. Immunoglobulins and immunoglobulin genes of the horse. Dev. Comp. Immunol. 2006, 30:155-164.
42. Wagner B., Hillegas J.M., Brinker D.R., Horohov D.W., Antczak D.F. Characterization of monoclonal antibodies to equine interleukin-10 and detection of T regulatory 1 cells in horses. Vet. Immunol. Immunopathol. 2008, 122:57-64.
43. Wagner B., Glaser A., Hillegas J.M., Erb H.N., Gold C., Freer H. Monoclonal antibodies to equine IgM improve the sensitivity of West Nile virus-specific IgM detection in horses. Vet. Immunol. Immunopathol. 2008, 122:46-56.
44. + cells after crosslinking of maternal IgE. Dev. Comp. Immunol. 2010, 34:436-444.
45. Wang F., Kikutani H., Tsang S.F., Kishimoto T., Kieff E. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element. J. Virol. 1991, 65:4101-4106.
46. Watson J.L., Jackson K.A., King D.P., Stott J.L. Molecular cloning and sequencing of the low-affinity IgE receptor (CD23) for horse and cattle. Vet. Immunol. Immunopathol. 2000, 73:323-329.
47. Weskamp G., Ford J.W., Sturgill J., Martin S., Docherty A.J., Swendeman S., Broadway N., Hartmann D., Saftig P., Umland S., Sehara-Fujisawa A., Black R.A., Ludwig A., Becherer J.D., Conrad D.H., Blobel C.P. ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. Nat. Immunol. 2006, 7:1293-1298.
48. Yokota A., Kikutani H., Tanaka T., Sato R., Barsumian E.L., Suemura M., Kishimoto T. Two species of human Fc e{open} receptor II (Fce{open}RII/CD23): tissue-specific and IL-4 specific regulation of gene expression. Cell 1988, 55:611-618.
49. Yu L.C., Montagnac G., Yang P.C., Conrad D.H., Benmerah A., Perdue M.H. Intestinal epithelial CD23 mediates enhanced antigen transport in allergy: evidence for novel splice forms. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 285:G223-G234.